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Abstract
Our case involves persistent hiccup arising in anadolescentwith obsessive compulsive disorder (OCD)whowasusing aripiprazole
as an augmentation to fluoxetine and whose hiccups remitted with dose reduction and rechallenge. Treatment suggested that
aripiprazolemight lead to hiccups. Antipsychotics are also used for the treatment of hiccups, but recent case reports suggest that
they cause hiccups as well. Within 12 h of taking 5 mg aripiprazole, the 13-year-old girl began having continuous hiccups, which
lasted for 3–4 h. The hiccups resolvedwhen the dose of aripiprazolewas reduced to 2.5 mg. To achieve augmentation, aripiprazole
was replacedwith risperidone 0.5 mg/day for 1month, but excess sedationwas observed. As a result, aripiprazolewas restarted at
a dose of 2.5 mg/day, and 1 week later, it was increased to 5 mg/every other day. No hiccups were observed.
INTRODUCTION
‘Hiccup’ is a repetitive, involuntary, spasmodic and characteristic
sound that appears with sudden closure of the glottis as a conse-
quence of involuntary contraction of the diaphragm and respira-
tory muscles [1]. Although the pathophysiological processes that
cause hiccups have not been fully determined, central nervous
system disorders, gastrointestinal disorders such as gastric dis-
tension and reflux, head and neck diseases, metabolic disorders,
electrolyte disorders and some drugs are posited as causes of
hiccups [1].
Among drug-induced hiccups, aripiprazole, a dopaminergic
stabilizing agent, is often cited, both for transient and persistent
hiccups among adult and adolescent patients [2–6]. As far as we
are aware, hiccups in these patients arose while switching treat-
ments and did not involve dose titration and rechallenge. Here,
we present persistent hiccups arising in adolescent with obses-
sive compulsive disorder (OCD) who was using aripiprazole as
an augmentation to fluoxetine and whose hiccups remitted
with dose reduction and rechallenge.
CASE REPORT
The patient was a 13-year-old girl who was referred to the out-
patient clinic with complaints of controlling, counting, a need
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for symmetry and excessive washing. She was diagnosed with
OCD 4 years ago by a child and adolescent psychiatrist and has
received sertraline up to 200 mg/day along with intermittent
exposure response prevention for 4 years, with no significant
benefit. Mental status examination revealed obsessions of
doubt, symmetry, ordering, contamination and religiosity,
checking, ordering and mental compulsions along with depres-
sive symptoms. Developmental milestones were normal with
no evidence of tics. Family history revealed maternal OCD with
a positive response to fluoxetine. Baseline psychometric evalua-
tions revealed C-YBOCS and CGI-S scores of 35 and 6, respective-
ly. Accordingly, the diagnosis of OCD was confirmed, and
sertraline was cross-tapered with fluoxetine up to 60 mg/day on
the 16thweek of treatment. Evaluation at the 4thmonth revealed
C-YBOCS and CGI-S scores of 31 and 5, respectively, which sug-
gests minimal benefit. Aripiprazole 5 mg/day was added there-
fore, for augmentation. The patient and her family reported
that persistent hiccups started 12 h after the initial dose and con-
tinued for a week. After this, the parents immediately reduced
the dose to 2.5 mg/day, leading to the cessation of hiccups. To
achieve augmentation, aripiprazole was replaced with risperi-
done 0.5 mg/day for 1 month, but excess sedation was observed.
Consequently, aripiprazole was restarted at 2.5 mg/day. One
week later, the dose was increased to 5 mg/every other day
with no occurrence of hiccups. She was followed for 8 weeks
without hiccups, and her C-YBOCS and CGI-S scores were
found to be 15 and 3, respectively, denoting treatment response.
Evaluationwith theNaranjo algorithmrevealed a scoreof 7 (prob-
ably adverse drug reaction) [7].
DISCUSSION
Here, we report a female adolescent with OCD who developed
persistent hiccups with aripiprazole augmentation of fluoxetine
treatment, whose hiccups remitted with dose reduction and did
not appear with a rechallenge. Although previous reports of per-
sistent and transient hiccups with aripiprazole exist, our case is
unique in that the adverse reaction responded to dose reduction
and did not appear with rechallenge [2–6]. Although the exact
roles of neurotransmitters within the reflex arc of hiccups are
not known, antipsychotics are used in the management of hic-
cups [8]. Existing data suggest that both dopamine and serotonin
may play a role in the generation of hiccups [2–6,8]. Previous re-
ports posited that both hypo- and hyper-dopaminergic states
may lead to hiccups [2–6,8]. However, there are several other al-
ternative explanations in our case. First, elimination of aripipra-
zole involves two cytochrome P450 isoenzymes (CYP2D6 and
CYP3A4) and fluoxetine, which is a potent inhibitor of CYP2D6,
can block the metabolism of aripiprazole and increase its blood
levels [9]. Second, partial agonistic at 5-HT1A and antagonistic ef-
fects at 5-HT2A receptors of aripiprazolewithin the spinal cord at
the level of the phrenic nerve, perhaps potentiated by fluoxetine,
may have caused the hiccups [10]. Lastly, as posited before, either
hypo- or hyper-dopaminergic statesmay cause hiccups as shown
before [2–6]. The temporal profiles of hiccups in our patient, their
remission with dose reduction and their lack of re-occurrence
with challenge, suggest, however, a mechanism of potentiation
of its effects probably via CYP450. Regardless of exact etiology,
it may be prudent for the clinicians to be aware of this rare
adverse effect.
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